Advances in the surgical management of inflammatory bowel disease
10.3760/cma.j.cn115610-20240416-00205
- VernacularTitle:炎症性肠病的外科治疗进展
- Author:
Ping LAN
1
;
Zongjin ZHANG
;
Zhen HE
Author Information
1. 中山大学附属第六医院普通外科（结直肠外科）广东省结直肠盆底疾病研究重点实验室 广州市黄埔区中六生物医学创新研究院 人体微生态与老年慢性疾病教育部重点实验室，广州 510655
- Keywords:
Inflammatory bowel disease;
Crohn′s disease;
Ulcerative colitis;
Surgical management;
Efficacy
- From:
Chinese Journal of Digestive Surgery
2024;23(6):775-781
- CountryChina
- Language:Chinese
-
Abstract:
Inflammatory bowel disease (IBD) is a chronic, progressive inflammatory disease of the gastrointestinal tract. With prolonged disease duration, more than 70% of patients with Crohn′s disease (CD) and nearly one-third of patients with ulcerative colitis (UC) eventually require surgical intervention. Individualized factors, such as disease phenotype, severity, preoperative medications, surgical history, surgeon′s experience, and surgical technique adopted affect the short-term post-operative complications and long-term prognosis of IBD. The goals of surgical treatment of CD are to reduce complications, avoid or delay postoperative recurrence, and improve quality of life. In recent years, the surgical concepts and techniques of CD represented by preoperative optimization, restric-tive bowel resection, early surgery, extensive mesenteric resection, and Kono-S anastomosis have been improved and developed. Total proctocolectomy plus ileal pouch-anal anastomosis (IPAA) is the preferred surgical procedure of UC, and the evolution of IPAA staging and optimization of tech-nical details have further improved the efficacy. With the innovation of IBD treatment concepts and modalities, a standardized surgical treatment system is gradually being formed, which will further improve the efficacy of IBD treatment. Based on the relevant literature and practical experience, the authors review the latest progress of surgical treatment of IBD, aiming to promote the standardized treatment of IBD surgery.
